161 related articles for article (PubMed ID: 9338582)
1. Evidence for founder effect of the Glu104Asp substitution and identification of new mutations in triosephosphate isomerase deficiency.
Arya R; Lalloz MR; Bellingham AJ; Layton DM
Hum Mutat; 1997; 10(4):290-4. PubMed ID: 9338582
[TBL] [Abstract][Full Text] [Related]
2. Triosephosphate isomerase deficiency: facts and doubts.
Orosz F; Oláh J; Ovádi J
IUBMB Life; 2006 Dec; 58(12):703-15. PubMed ID: 17424909
[TBL] [Abstract][Full Text] [Related]
3. Triosephosphate isomerase deficiency: a patient with Val231Met mutation.
Serdaroglu G; Aydinok Y; Yilmaz S; Manco L; Ozer E
Pediatr Neurol; 2011 Feb; 44(2):139-42. PubMed ID: 21215915
[TBL] [Abstract][Full Text] [Related]
4. The 1591C mutation in triosephosphate isomerase (TPI) deficiency. Tightly linked polymorphisms and a common haplotype in all known families.
Schneider A; Westwood B; Yim C; Cohen-Solal M; Rosa R; Labotka R; Eber S; Wolf R; Lammi A; Beutler E
Blood Cells Mol Dis; 1996; 22(2):115-25. PubMed ID: 8931952
[TBL] [Abstract][Full Text] [Related]
5. Triose phosphate isomerase deficiency associated with two novel mutations in TPI gene.
Fermo E; Bianchi P; Vercellati C; Rees DC; Marcello AP; Barcellini W; Zanella A
Eur J Haematol; 2010 Aug; 85(2):170-3. PubMed ID: 20374271
[TBL] [Abstract][Full Text] [Related]
6. Missense variant in TPI1 (Arg189Gln) causes neurologic deficits through structural changes in the triosephosphate isomerase catalytic site and reduced enzyme levels in vivo.
Roland BP; Richards KR; Hrizo SL; Eicher S; Barile ZJ; Chang TC; Savon G; Bianchi P; Fermo E; Ricerca BM; Tortorolo L; Vockley J; VanDemark AP; Palladino MJ
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2257-2266. PubMed ID: 31075491
[TBL] [Abstract][Full Text] [Related]
7. Triose phosphate isomerase deficiency is caused by altered dimerization--not catalytic inactivity--of the mutant enzymes.
Ralser M; Heeren G; Breitenbach M; Lehrach H; Krobitsch S
PLoS One; 2006 Dec; 1(1):e30. PubMed ID: 17183658
[TBL] [Abstract][Full Text] [Related]
8. Distinct behavior of mutant triosephosphate isomerase in hemolysate and in isolated form: molecular basis of enzyme deficiency.
Orosz F; Oláh J; Alvarez M; Keseru GM; Szabó B; Wágner G; Kovári Z; Horányi M; Baróti K; Martial JA; Hollán S; Ovádi J
Blood; 2001 Nov; 98(10):3106-12. PubMed ID: 11698297
[TBL] [Abstract][Full Text] [Related]
9. New haplotype for the Glu104Asp mutation in triose-phosphate isomerase deficiency and prenatal diagnosis in a Spanish family.
Repiso A; Corrons JL; Vulliamy T; Killeen N; Layton M; Carreras J; Climent F
J Inherit Metab Dis; 2005; 28(5):807-9. PubMed ID: 16151918
[TBL] [Abstract][Full Text] [Related]
10. Hemolytic anemia and progressive neurologic impairment: think about triosephosphate isomerase deficiency.
Aissa K; Kamoun F; Sfaihi L; Ghedira ES; Aloulou H; Kamoun T; Pissard S; Hachicha M
Fetal Pediatr Pathol; 2014 Aug; 33(4):234-8. PubMed ID: 24840153
[TBL] [Abstract][Full Text] [Related]
11. Triosephosphate isomerase deficiency: historical perspectives and molecular aspects.
Schneider AS
Baillieres Best Pract Res Clin Haematol; 2000 Mar; 13(1):119-40. PubMed ID: 10916682
[TBL] [Abstract][Full Text] [Related]
12. Triosephosphate isomerase deficiency: Effect of F240L mutation on enzyme structure.
Romero JM
Arch Biochem Biophys; 2020 Aug; 689():108473. PubMed ID: 32585311
[TBL] [Abstract][Full Text] [Related]
13. Reappraisal of triosephosphate isomerase deficiency.
Orosz F; Oláh J; Ovádi J
Eur J Haematol; 2011 Mar; 86(3):265-7. PubMed ID: 20546019
[No Abstract] [Full Text] [Related]
14. A common ancestral glycoprotein (GP) 9 1828A>G (Asn45Ser) gene mutation occurring in European families from Australia and Northern Europe with Bernard-Soulier Syndrome (BSS).
Liang HP; Morel-Kopp MC; Clemetson JM; Clemetson KJ; Kekomaki R; Kroll H; Michaelides K; Tuddenham EG; Vanhoorelbeke K; Ward CM
Thromb Haemost; 2005 Sep; 94(3):599-605. PubMed ID: 16268478
[TBL] [Abstract][Full Text] [Related]
15. Triosephosphate isomerase deficiency with elevated sweat chloride test: report of a case.
Yenicesu I; Kalayci O; Semizel E; Kavak U; Gümrük F; Ferec C; Beutler E
Turk J Pediatr; 2000; 42(4):319-21. PubMed ID: 11196750
[TBL] [Abstract][Full Text] [Related]
16. Triosephosphate isomerase deficiency: repetitive occurrence of point mutation in amino acid 104 in multiple apparently unrelated families.
Schneider A; Westwood B; Yim C; Prchal J; Berkow R; Labotka R; Warrier R; Beutler E
Am J Hematol; 1995 Dec; 50(4):263-8. PubMed ID: 7485100
[TBL] [Abstract][Full Text] [Related]
17. Human triosephosphate isomerase deficiency resulting from mutation of Phe-240.
Chang ML; Artymiuk PJ; Wu X; Hollán S; Lammi A; Maquat LE
Am J Hum Genet; 1993 Jun; 52(6):1260-9. PubMed ID: 8503454
[TBL] [Abstract][Full Text] [Related]
18. Eight novel mutations and consequences on mRNA and protein level in pyruvate kinase-deficient patients with nonspherocytic hemolytic anemia.
Kugler W; Willaschek C; Holtz C; Ohlenbusch A; Laspe P; Krügener R; Muirhead H; Schröter W; Lakomek M
Hum Mutat; 2000; 15(3):261-72. PubMed ID: 10679942
[TBL] [Abstract][Full Text] [Related]
19. Age and origin of major Smith-Lemli-Opitz syndrome (SLOS) mutations in European populations.
Witsch-Baumgartner M; Schwentner I; Gruber M; Benlian P; Bertranpetit J; Bieth E; Chevy F; Clusellas N; Estivill X; Gasparini G; Giros M; Kelley RI; Krajewska-Walasek M; Menzel J; Miettinen T; Ogorelkova M; Rossi M; Scala I; Schinzel A; Schmidt K; Schönitzer D; Seemanova E; Sperling K; Syrrou M; Talmud PJ; Wollnik B; Krawczak M; Labuda D; Utermann G
J Med Genet; 2008 Apr; 45(4):200-9. PubMed ID: 17965227
[TBL] [Abstract][Full Text] [Related]
20. Glucosephosphate isomerase (GPI) deficiency mutations associated with hereditary nonspherocytic hemolytic anemia (HNSHA).
Beutler E; West C; Britton HA; Harris J; Forman L
Blood Cells Mol Dis; 1997 Dec; 23(3):402-9. PubMed ID: 9446754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
